Rigel Pharmaceuticals Inc (RIGL)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -65.957 | -79.081 | -54.589 | -46.668 | -23.062 | -12.901 | -38.841 | -19.953 |
Return on Equity (%) | -94.552 | -100.2 | -66.957 | -81.732 | -67.722 | -55.634 | -699.045 | 118.746 |
Return on Invested Capital (%) | -96.505 | -103.326 | -69.558 | -80.305 | -49.977 | -25.605 | -148.852 | -84.555 |
Operating Margin (%) | -339.577 | -1739.34 | -158.35 | -112.264 | -26.138 | -8.342 | -45.63 | -15.588 |
Net Profit Margin (%) | -339.577 | -1739.34 | -158.35 | -112.829 | -27.383 | -12.004 | -48.713 | -21.467 |
Book Value Per Share | 0.554 | 0.686 | 0.657 | 0.32 | 0.201 | 0.177 | -0.165 | -0.244 |
Earnings Per Share | -0.697 | -0.531 | -0.422 | -0.398 | -0.176 | -0.104 | -0.338 | -0.144 |
Cash Per Share | 0.178 | 0.261 | 0.457 | 0.134 | 0.179 | 0.11 | 0.141 | 0.188 |
Working Capital Per Share | 0.54 | 0.675 | 0.654 | 0.362 | 0.284 | 0.53 | 0.292 | 0.264 |
Operating Profit Per Share | 0.205 | 0.031 | 0.265 | 0.352 | 0.64 | 0.863 | 0.683 | 0.63 |
EBIT Per Share | -0.697 | -0.531 | -0.422 | -0.398 | -0.176 | -0.101 | -0.338 | -0.144 |
EBITDA Per Share | -0.697 | -0.531 | -0.422 | -0.398 | -0.176 | -0.101 | -0.338 | -0.144 |
Free Cash Flow Per Share | -0.699 | -0.533 | -0.419 | -0.394 | -0.172 | -0.108 | -0.341 | -0.065 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 99,27M | 146,82M | 167,17M | 167,99M | 169,32M | 171,6M | 173,4M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 173,4M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -47.303 | N/A | N/A | N/A | -21.579 | N/A | N/A |
Net Profit Margin (%) | N/A | -51.922 | N/A | N/A | N/A | -27.924 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 384,18M |
Ratio cours/bénéfice | -15,31 |
Ratio prix/ventes | 3,29 |
Ratio prix/liquidités | 11,72 |
Ratio prix/valeur comptable | -13,41 |
Rendement de dividende | - |
Actions en circulation | 17,62M |
Volume moyen (1 semaine) | 299,42k |
Volume moyen (1 mois) | 368,17k |
Variation sur 52 semaines | 61,56% |
Plus haut sur 52 semaines | 29,82 |
Plus bas sur 52 semaines | 7,4843 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales